ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
65
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,097
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Angiotensin II type 1 receptor blockers.
Author(s):
M Burnier
Publication date:
2001-02-13
Journal:
Circulation
Keywords:
Angiotensin I
,
metabolism
,
Angiotensin II
,
Angiotensin Receptor Antagonists
,
Angiotensin-Converting Enzyme Inhibitors
,
pharmacology
,
Animals
,
Antihypertensive Agents
,
pharmacokinetics
,
Benzimidazoles
,
Binding, Competitive
,
Biphenyl Compounds
,
Blood Pressure
,
drug effects
,
Drug Design
,
Humans
,
Losartan
,
Peptidyl-Dipeptidase A
,
Protein Binding
,
Receptor, Angiotensin, Type 1
,
Receptor, Angiotensin, Type 2
,
Receptors, Angiotensin
,
classification
,
physiology
,
Renin-Angiotensin System
,
Saralasin
,
Tetrazoles
,
Valine
,
analogs & derivatives
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
EPA CompTox Chemicals Dashboard
Author and article information
Journal
PubMed ID::
11171802
DOI::
10.1161/01.cir.103.6.904
ScienceOpen disciplines:
Chemistry
Keywords:
Angiotensin I
,
metabolism
,
Angiotensin II
,
Angiotensin Receptor Antagonists
,
Angiotensin-Converting Enzyme Inhibitors
,
pharmacology
,
Animals
,
Antihypertensive Agents
,
pharmacokinetics
,
Benzimidazoles
,
Binding, Competitive
,
Biphenyl Compounds
,
Blood Pressure
,
drug effects
,
Drug Design
,
Humans
,
Losartan
,
Peptidyl-Dipeptidase A
,
Protein Binding
,
Receptor, Angiotensin, Type 1
,
Receptor, Angiotensin, Type 2
,
Receptors, Angiotensin
,
classification
,
physiology
,
Renin-Angiotensin System
,
Saralasin
,
Tetrazoles
,
Valine
,
analogs & derivatives
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Angiotensin I
,
metabolism
,
Angiotensin II
,
Angiotensin Receptor Antagonists
,
Angiotensin-Converting Enzyme Inhibitors
,
pharmacology
,
Animals
,
Antihypertensive Agents
,
pharmacokinetics
,
Benzimidazoles
,
Binding, Competitive
,
Biphenyl Compounds
,
Blood Pressure
,
drug effects
,
Drug Design
,
Humans
,
Losartan
,
Peptidyl-Dipeptidase A
,
Protein Binding
,
Receptor, Angiotensin, Type 1
,
Receptor, Angiotensin, Type 2
,
Receptors, Angiotensin
,
classification
,
physiology
,
Renin-Angiotensin System
,
Saralasin
,
Tetrazoles
,
Valine
,
analogs & derivatives
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,097
Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational Study
Authors:
Gyu Chul Oh
,
Kwon Joo
,
Myung-A Kim
…
20-Hydroxyeicosatetraenoic Acid Contributes to the Inhibition of K+ Channel Activity and Vasoconstrictor Response to Angiotensin II in Rat Renal Microvessels
Authors:
Fan Fan
,
Cheng-wen Sun
,
Kristopher Maier
…
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
Authors:
Lidia Anguiano
,
Marta Riera
,
Julio Pascual
…
See all similar
Cited by
63
Rosetta FlexPepDock ab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors
Authors:
Barak Raveh
,
Nir London
,
Lior Zimmerman
…
Drugs, their targets and the nature and number of drug targets.
Authors:
Peter Imming
,
Christian Sinning
,
Achim Meyer
Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
Authors:
Monika Gaba
,
Chander Mohan
See all cited by